ArticleJAMA oncology2018

Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.

Virginia F Borges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.